Skip to main content
Top
Published in: BMC Oral Health 1/2023

Open Access 01-12-2023 | Tooth Extraction | Research

The predictive value of pretreatment hemoglobin-to-platelet ratio on osteoradionecrosis incidence rates of locally advanced nasopharyngeal cancer patients managed with concurrent chemoradiotherapy

Authors: Busra Yilmaz, Efsun Somay, Erkan Topkan, Ahmet Kucuk, Berrin Pehlivan, Ugur Selek

Published in: BMC Oral Health | Issue 1/2023

Login to get access

Abstract

Background

This retrospective study aimed to investigate whether the pretreatment hemoglobin-to-platelet ratio (HPR) could predict the risk of osteoradionecrosis (ORN) in patients receiving concurrent chemoradiotherapy (C-CRT) for locally advanced nasopharyngeal carcinoma (LA-NPC).

Methods

ORN cases were reported from the records of LA-NPC patients who had oral examinations before and after C-CRT. The pretreatment HPR values were calculated on the first day of C-CRT. The connection between HPR values and ORN occurrences was determined using receiver operating characteristic curve analysis. The primary endpoint was the relationship between the pretreatment HPR values and post-C-CRT ORN incidence rates, while secondary endpoints included the identification of other putative ORN risk factors.

Results

We distinguished 10.9% incidences of ORN during the post-C-CRT follow-up period among 193 LA-NPC patients. The optimal cutoff for pre-C-CRT HPR was 0.48 that grouped the patients into two HPR groups with fundamentally different post-C-CRT ORN incidence rates: Group 1: HPR ≤ 0.48 (N = 60), and Group 2: HPR > 0.48 (N = 133). The comparative analysis indicated a significantly higher ORN incidence in HPR ≤ 0.48 group (30%; P < 0.001). The other factors associated with meaningfully increased ORN rates included the presence of pre-C-CRT ≥ 5 teeth extractions, mandibular volume receiving ≥ 64 Gy, post-C-CRT tooth extractions, mean mandibular dose ≥ 50.6 Gy, and C-CRT to tooth extraction interval > 5.5 months.

Conclusion

Low pretreatment HPR levels were independently and unequivocally linked to significantly increased incidence of ORN post-C-CRT. Pre-C-CRT HPR levels may be used to estimate the incidence of ORN and be useful for taking preventive and therapeutic measures in these patients such as monitoring oral hygiene with strict follow-up, avoidance of unnecessary tooth extractions, particularly after C-CRT, and use of more rigorous mandibular RT dose limits.
Appendix
Available only for authorised users
Literature
1.
go back to reference Baujat B, Audry H, Bourhis J, Chan AT, Onat H, Chua DT, et al. Chemotherapy in locally advanced nasopharyngeal carcinoma: an individual patient data meta-analysis of eight randomized trials and 1753 patients. Int J Radiat Oncol Biol Phys. 2006;64:47–56.PubMedCrossRef Baujat B, Audry H, Bourhis J, Chan AT, Onat H, Chua DT, et al. Chemotherapy in locally advanced nasopharyngeal carcinoma: an individual patient data meta-analysis of eight randomized trials and 1753 patients. Int J Radiat Oncol Biol Phys. 2006;64:47–56.PubMedCrossRef
2.
go back to reference De Felice F, Musio D, Terenzi V, Valentini V, Cassoni A, Tombolini M, et al. Treatment improvement and better patient care: which is the most important one in oral cavity cancer? Radiat Oncol. 2014;9:263.PubMedPubMedCentralCrossRef De Felice F, Musio D, Terenzi V, Valentini V, Cassoni A, Tombolini M, et al. Treatment improvement and better patient care: which is the most important one in oral cavity cancer? Radiat Oncol. 2014;9:263.PubMedPubMedCentralCrossRef
3.
go back to reference De Felice F, de Vincentiis M, Luzzi V, Magliulo G, Tombolini M, Ruoppolo G, et al. Late radiation-associated dysphagia in head and neck cancer patients: evidence, research and management. Oral Oncol. 2018;77:125–30.PubMedCrossRef De Felice F, de Vincentiis M, Luzzi V, Magliulo G, Tombolini M, Ruoppolo G, et al. Late radiation-associated dysphagia in head and neck cancer patients: evidence, research and management. Oral Oncol. 2018;77:125–30.PubMedCrossRef
4.
go back to reference Pignon JP, le Maître A, Maillard E, Bourhis J, MACH-NC Collaborative Group. Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): an update on 93 randomised trials and 17,346 patients. Radiother Oncol. 2009;92:4–14.PubMedCrossRef Pignon JP, le Maître A, Maillard E, Bourhis J, MACH-NC Collaborative Group. Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): an update on 93 randomised trials and 17,346 patients. Radiother Oncol. 2009;92:4–14.PubMedCrossRef
5.
go back to reference Meleca JB, Zhang E, Fritz MA, Ciolek PJ. Overview and emerging Trends in the treatment of osteoradionecrosis. Curr Treat Options Oncol. 2021;22:115.CrossRef Meleca JB, Zhang E, Fritz MA, Ciolek PJ. Overview and emerging Trends in the treatment of osteoradionecrosis. Curr Treat Options Oncol. 2021;22:115.CrossRef
6.
go back to reference Chapchay K, Weinberger J, Eliashar R, Adler N. Anterior Skull Base Reconstruction following ablative surgery for osteoradionecrosis: Case Report and Review of Literature. Ann Otol Rhinol Laryngol. 2019;128:1134–40.PubMedCrossRef Chapchay K, Weinberger J, Eliashar R, Adler N. Anterior Skull Base Reconstruction following ablative surgery for osteoradionecrosis: Case Report and Review of Literature. Ann Otol Rhinol Laryngol. 2019;128:1134–40.PubMedCrossRef
7.
go back to reference Jawad H, Hodson NA, Nixon PJ. A review of dental treatment of head and neck cancer patients, before, during and after radiotherapy: part 1. Br Dent J. 2015;218:65–8.PubMedCrossRef Jawad H, Hodson NA, Nixon PJ. A review of dental treatment of head and neck cancer patients, before, during and after radiotherapy: part 1. Br Dent J. 2015;218:65–8.PubMedCrossRef
8.
go back to reference Jawad H, Hodson NA, Nixon PJ. A review of dental treatment of head and neck cancer patients, before, during and after radiotherapy: part 2. Br Dent J. 2015;218:69–74.PubMedCrossRef Jawad H, Hodson NA, Nixon PJ. A review of dental treatment of head and neck cancer patients, before, during and after radiotherapy: part 2. Br Dent J. 2015;218:69–74.PubMedCrossRef
9.
go back to reference Buglione M, Cavagnini R, Di Rosario F, Sottocornola L, Maddalo M, Vassalli L, et al. Oral toxicity management in head and neck cancer patients treated with chemotherapy and radiation: Dental pathologies and osteoradionecrosis (part 1) literature review and consensus statement. Crit Rev Oncol Hematol. 2016;97:131–42.PubMedCrossRef Buglione M, Cavagnini R, Di Rosario F, Sottocornola L, Maddalo M, Vassalli L, et al. Oral toxicity management in head and neck cancer patients treated with chemotherapy and radiation: Dental pathologies and osteoradionecrosis (part 1) literature review and consensus statement. Crit Rev Oncol Hematol. 2016;97:131–42.PubMedCrossRef
10.
go back to reference Nooh N. Dental implant survival in irradiated oral cancer patients: a systematic review of the literature. Int J Oral Maxillofac Implants. 2013;28:1233–42.PubMedCrossRef Nooh N. Dental implant survival in irradiated oral cancer patients: a systematic review of the literature. Int J Oral Maxillofac Implants. 2013;28:1233–42.PubMedCrossRef
11.
go back to reference Chrcanovic BR, Albrektsson T, Wennerberg A. Dental implants in irradiated versus nonirradiated patients: a meta-analysis. Head Neck. 2016;38:448–81.PubMedCrossRef Chrcanovic BR, Albrektsson T, Wennerberg A. Dental implants in irradiated versus nonirradiated patients: a meta-analysis. Head Neck. 2016;38:448–81.PubMedCrossRef
12.
go back to reference Epstein JB, Rea G, Wong FL, Spinelli J, Stevenson-Moore P. Osteonecrosis: study of the relationship of dental extractions in patients receiving radiotherapy. Head Neck Surg. 1987;10:48–54.PubMedCrossRef Epstein JB, Rea G, Wong FL, Spinelli J, Stevenson-Moore P. Osteonecrosis: study of the relationship of dental extractions in patients receiving radiotherapy. Head Neck Surg. 1987;10:48–54.PubMedCrossRef
13.
go back to reference Cheng VS, Wang CC. Osteoradionecrosis of the mandible resulting from external megavoltage radiation therapy. Radiology. 1974;112:685–9.PubMedCrossRef Cheng VS, Wang CC. Osteoradionecrosis of the mandible resulting from external megavoltage radiation therapy. Radiology. 1974;112:685–9.PubMedCrossRef
14.
go back to reference Rankow RM, Weissman B. Osteoradionecrosis of the mandible. Ann Otol Rhinol Laryngol. 1971;80:603–11.PubMedCrossRef Rankow RM, Weissman B. Osteoradionecrosis of the mandible. Ann Otol Rhinol Laryngol. 1971;80:603–11.PubMedCrossRef
15.
go back to reference Morrish RB Jr, Chan E, Silverman S Jr, Meyer J, Fu KK, Greenspan D. Osteonecrosis in patients irradiated for head and neck carcinoma. Cancer. 1981;47:1980–3.PubMedCrossRef Morrish RB Jr, Chan E, Silverman S Jr, Meyer J, Fu KK, Greenspan D. Osteonecrosis in patients irradiated for head and neck carcinoma. Cancer. 1981;47:1980–3.PubMedCrossRef
16.
go back to reference Moon DH, Moon SH, Wang K, Weissler MC, Hackman TG, Zanation AM, et al. Incidence of, and risk factors for, mandibular osteoradionecrosis in patients with oral cavity and oropharynx cancers. Oral Oncol. 2017;72:98–103.PubMedCrossRef Moon DH, Moon SH, Wang K, Weissler MC, Hackman TG, Zanation AM, et al. Incidence of, and risk factors for, mandibular osteoradionecrosis in patients with oral cavity and oropharynx cancers. Oral Oncol. 2017;72:98–103.PubMedCrossRef
17.
go back to reference Caparrotti F, Huang SH, Lu L, Bratman SV, Ringash J, Bayley A, et al. Osteoradionecrosis of the mandible in patients with oropharyngeal carcinoma treated with intensity-modulated radiotherapy. Cancer. 2017;123:3691–700.PubMedCrossRef Caparrotti F, Huang SH, Lu L, Bratman SV, Ringash J, Bayley A, et al. Osteoradionecrosis of the mandible in patients with oropharyngeal carcinoma treated with intensity-modulated radiotherapy. Cancer. 2017;123:3691–700.PubMedCrossRef
18.
go back to reference Mirabile A, Numico G, Russi EG, Bossi P, Crippa F, Bacigalupo A, et al. Sepsis in head and neck cancer patients treated with chemotherapy and radiation: literature review and consensus. Crit Rev Oncol Hematol. 2015;95:191–213.PubMedCrossRef Mirabile A, Numico G, Russi EG, Bossi P, Crippa F, Bacigalupo A, et al. Sepsis in head and neck cancer patients treated with chemotherapy and radiation: literature review and consensus. Crit Rev Oncol Hematol. 2015;95:191–213.PubMedCrossRef
19.
go back to reference Costantino PD, Friedman CD, Steinberg MJ. Irradiated bone and its management. Otolaryngol Clin North Am. 1995;28:1021–38.PubMedCrossRef Costantino PD, Friedman CD, Steinberg MJ. Irradiated bone and its management. Otolaryngol Clin North Am. 1995;28:1021–38.PubMedCrossRef
20.
go back to reference Oh HK, Chambers MS, Garden AS, Wong PF, Martin JW. Risk of osteoradionecrosis after extraction of impacted third molars in irradiated head and neck cancer patients. J Oral Maxillofac Surg. 2004;62:139–44.PubMedCrossRef Oh HK, Chambers MS, Garden AS, Wong PF, Martin JW. Risk of osteoradionecrosis after extraction of impacted third molars in irradiated head and neck cancer patients. J Oral Maxillofac Surg. 2004;62:139–44.PubMedCrossRef
21.
go back to reference Støre G, Boysen M. Mandibular osteoradionecrosis: clinical behaviour and diagnostic aspects. Clin Otolaryngol Allied Sci. 2000;25:378–84.PubMedCrossRef Støre G, Boysen M. Mandibular osteoradionecrosis: clinical behaviour and diagnostic aspects. Clin Otolaryngol Allied Sci. 2000;25:378–84.PubMedCrossRef
22.
go back to reference Morrish RB Jr, Chan E, Silverman S Jr, Meyer J, Fu KK, Greenspan D. Osteonecrosis in patients irradiated for head and neck carcinoma. Cancer. 1981;47:1980–3.PubMedCrossRef Morrish RB Jr, Chan E, Silverman S Jr, Meyer J, Fu KK, Greenspan D. Osteonecrosis in patients irradiated for head and neck carcinoma. Cancer. 1981;47:1980–3.PubMedCrossRef
23.
go back to reference Horiot JC, Bone MC, Ibrahim E, Castro JR. Systematic dental management in head and neck irradiation. Int J Radiat Oncol Biol Phys. 1981;7:1025–9.PubMedCrossRef Horiot JC, Bone MC, Ibrahim E, Castro JR. Systematic dental management in head and neck irradiation. Int J Radiat Oncol Biol Phys. 1981;7:1025–9.PubMedCrossRef
24.
go back to reference Marx RE, Johnson RP. Studies in the radiobiology of osteoradionecrosis and their clinical significance. Oral Surg Oral Med Oral Pathol. 1987;64:379–90.PubMedCrossRef Marx RE, Johnson RP. Studies in the radiobiology of osteoradionecrosis and their clinical significance. Oral Surg Oral Med Oral Pathol. 1987;64:379–90.PubMedCrossRef
25.
go back to reference Thorn JJ, Hansen HS, Specht L, Bastholt L. Osteoradionecrosis of the jaws: clinical characteristics and relation to the field of irradiation. J Oral Maxillofac Surg. 2000;58:1088–95.PubMedCrossRef Thorn JJ, Hansen HS, Specht L, Bastholt L. Osteoradionecrosis of the jaws: clinical characteristics and relation to the field of irradiation. J Oral Maxillofac Surg. 2000;58:1088–95.PubMedCrossRef
26.
go back to reference Dumoulin S, van Maanen A, Magremanne M. Dental prevention of maxillo-mandibular osteoradionecrosis: a ten-year retrospective study. J Stomatol Oral Maxillofac Surg. 2021;122:127–34.PubMedCrossRef Dumoulin S, van Maanen A, Magremanne M. Dental prevention of maxillo-mandibular osteoradionecrosis: a ten-year retrospective study. J Stomatol Oral Maxillofac Surg. 2021;122:127–34.PubMedCrossRef
27.
go back to reference Marx RE. Osteoradionecrosis: a new concept of its pathophysiology. J Oral Maxillofac Surg. 1983;41:283–8.PubMedCrossRef Marx RE. Osteoradionecrosis: a new concept of its pathophysiology. J Oral Maxillofac Surg. 1983;41:283–8.PubMedCrossRef
28.
29.
go back to reference Bras J, de Jonge HK, van Merkesteyn JP. Osteoradionecrosis of the mandible: pathogenesis. Am J Otolaryngol. 1990;11:244–50.PubMedCrossRef Bras J, de Jonge HK, van Merkesteyn JP. Osteoradionecrosis of the mandible: pathogenesis. Am J Otolaryngol. 1990;11:244–50.PubMedCrossRef
30.
go back to reference Mo CJ, Hu ZJ, Qin SZ, Chen HP, Huang L, Li S, et al. Diagnostic value of platelet-lymphocyte ratio and hemoglobin-platelet ratio in patients with rectal cancer. J Clin Lab Anal. 2020;34:e23153.PubMedPubMedCentralCrossRef Mo CJ, Hu ZJ, Qin SZ, Chen HP, Huang L, Li S, et al. Diagnostic value of platelet-lymphocyte ratio and hemoglobin-platelet ratio in patients with rectal cancer. J Clin Lab Anal. 2020;34:e23153.PubMedPubMedCentralCrossRef
31.
32.
33.
34.
go back to reference Castillo-Rodríguez RA, Trejo-Solís C, Cabrera-Cano A, Gómez-Manzo S, Dávila-Borja VM. Hypoxia as a modulator of inflammation and immune response in cancer. Cancers (Basel). 2022;14:2291.PubMedCrossRef Castillo-Rodríguez RA, Trejo-Solís C, Cabrera-Cano A, Gómez-Manzo S, Dávila-Borja VM. Hypoxia as a modulator of inflammation and immune response in cancer. Cancers (Basel). 2022;14:2291.PubMedCrossRef
35.
go back to reference Dhanda J, Pasquier D, Newman L, Shaw R. Current concepts in Osteoradionecrosis after Head and Neck Radiotherapy. Clin Oncol (R Coll Radiol). 2016;28:459–66.PubMedCrossRef Dhanda J, Pasquier D, Newman L, Shaw R. Current concepts in Osteoradionecrosis after Head and Neck Radiotherapy. Clin Oncol (R Coll Radiol). 2016;28:459–66.PubMedCrossRef
36.
go back to reference Chrcanovic BR, Reher P, Sousa AA, Harris M. Osteoradionecrosis of the jaws–a current overview–part 1: physiopathology and risk and predisposing factors. Oral Maxillofac Surg. 2010;14:3–16.PubMedCrossRef Chrcanovic BR, Reher P, Sousa AA, Harris M. Osteoradionecrosis of the jaws–a current overview–part 1: physiopathology and risk and predisposing factors. Oral Maxillofac Surg. 2010;14:3–16.PubMedCrossRef
37.
go back to reference Albisinni S, Pretot D, Al Hajj Obeid W, Aoun F, Quackels T, Peltier A, et al. The impact of neutrophil-to-lymphocyte, platelet-to-lymphocyte and haemoglobin-to-platelet ratio on localised renal cell carcinoma oncologic outcomes. Prog Urol. 2019;29:423–31.PubMedCrossRef Albisinni S, Pretot D, Al Hajj Obeid W, Aoun F, Quackels T, Peltier A, et al. The impact of neutrophil-to-lymphocyte, platelet-to-lymphocyte and haemoglobin-to-platelet ratio on localised renal cell carcinoma oncologic outcomes. Prog Urol. 2019;29:423–31.PubMedCrossRef
38.
go back to reference Beresford MJ, Burcombe R, Ah-See ML, Stott D, Makris A. Pre-treatment haemoglobin levels and the prediction of response to neoadjuvant chemotherapy in breast cancer. Clin Oncol (R Coll Radiol). 2006;18:453–8.PubMedCrossRef Beresford MJ, Burcombe R, Ah-See ML, Stott D, Makris A. Pre-treatment haemoglobin levels and the prediction of response to neoadjuvant chemotherapy in breast cancer. Clin Oncol (R Coll Radiol). 2006;18:453–8.PubMedCrossRef
39.
go back to reference Zheng YY, Wu TT, Chen Y, Hou XG, Yang Y, Zhang JY, et al. Platelet-to-hemoglobin ratio as a novel predictor of long-term adverse outcomes in patients after percutaneous coronary intervention: a retrospective cohort study. Eur J Prev Cardiol. 2020;27:2216–9.PubMedCrossRef Zheng YY, Wu TT, Chen Y, Hou XG, Yang Y, Zhang JY, et al. Platelet-to-hemoglobin ratio as a novel predictor of long-term adverse outcomes in patients after percutaneous coronary intervention: a retrospective cohort study. Eur J Prev Cardiol. 2020;27:2216–9.PubMedCrossRef
40.
go back to reference White SC, Pharoah MJ. Oral Radiology-E-Book: principles and interpretation. Elsevier: St. Louis, Missouri;; 2018. pp. 808–32. White SC, Pharoah MJ. Oral Radiology-E-Book: principles and interpretation. Elsevier: St. Louis, Missouri;; 2018. pp. 808–32.
41.
go back to reference Yilmaz B, Somay E, Selek U, Topkan E. Pretreatment systemic Immune-Inflammation Index Predict needs for Teeth Extractions for locally Advanced Head and Neck Cancer Patients undergoing concurrent Chemoradiotherapy. Ther Clin Risk Manag. 2021;17:1113–21.PubMedPubMedCentralCrossRef Yilmaz B, Somay E, Selek U, Topkan E. Pretreatment systemic Immune-Inflammation Index Predict needs for Teeth Extractions for locally Advanced Head and Neck Cancer Patients undergoing concurrent Chemoradiotherapy. Ther Clin Risk Manag. 2021;17:1113–21.PubMedPubMedCentralCrossRef
42.
go back to reference Notani K, Yamazaki Y, Kitada H, Sakakibara N, Fukuda H, Omori K, et al. Management of mandibular osteoradionecrosis corresponding to the severity of osteoradionecrosis and the method of radiotherapy. Head Neck. 2003;25:181–6.PubMedCrossRef Notani K, Yamazaki Y, Kitada H, Sakakibara N, Fukuda H, Omori K, et al. Management of mandibular osteoradionecrosis corresponding to the severity of osteoradionecrosis and the method of radiotherapy. Head Neck. 2003;25:181–6.PubMedCrossRef
43.
go back to reference Caponio VCA, Troiano G, Togni L, Zhurakivska K, Santarelli A, Laino L, et al. Pattern and localization of perineural invasion predict poor survival in oral tongue carcinoma. Oral Dis. 2023;29(2):411–22.PubMedCrossRef Caponio VCA, Troiano G, Togni L, Zhurakivska K, Santarelli A, Laino L, et al. Pattern and localization of perineural invasion predict poor survival in oral tongue carcinoma. Oral Dis. 2023;29(2):411–22.PubMedCrossRef
45.
go back to reference Reuther T, Schuster T, Mende U, Kübler A. Osteoradionecrosis of the jaws as a side effect of radiotherapy of head and neck tumour patients–a report of a thirty year retrospective review. Int J Oral Maxillofac Surg. 2003;32:289–95.PubMedCrossRef Reuther T, Schuster T, Mende U, Kübler A. Osteoradionecrosis of the jaws as a side effect of radiotherapy of head and neck tumour patients–a report of a thirty year retrospective review. Int J Oral Maxillofac Surg. 2003;32:289–95.PubMedCrossRef
46.
go back to reference Owosho AA, Tsai CJ, Lee RS, Freymiller H, Kadempour A, Varthis S, et al. The prevalence and risk factors associated with osteoradionecrosis of the jaw in oral and oropharyngeal cancer patients treated with intensity-modulated radiation therapy (IMRT): the Memorial Sloan Kettering Cancer Center experience. Oral Oncol. 2017;64:44–51.PubMedCrossRef Owosho AA, Tsai CJ, Lee RS, Freymiller H, Kadempour A, Varthis S, et al. The prevalence and risk factors associated with osteoradionecrosis of the jaw in oral and oropharyngeal cancer patients treated with intensity-modulated radiation therapy (IMRT): the Memorial Sloan Kettering Cancer Center experience. Oral Oncol. 2017;64:44–51.PubMedCrossRef
47.
go back to reference Aarup-Kristensen S, Hansen CR, Forner L, Brink C, Eriksen JG, Johansen J. Osteoradionecrosis of the mandible after radiotherapy for head and neck cancer: risk factors and dose-volume correlations. Acta Oncol. 2019;58:1373–7.PubMedCrossRef Aarup-Kristensen S, Hansen CR, Forner L, Brink C, Eriksen JG, Johansen J. Osteoradionecrosis of the mandible after radiotherapy for head and neck cancer: risk factors and dose-volume correlations. Acta Oncol. 2019;58:1373–7.PubMedCrossRef
48.
go back to reference Khoo SC, Nabil S, Fauzi AA, Yunus SSM, Ngeow WC, Ramli R. Predictors of osteoradionecrosis following irradiated tooth extraction. Radiat Oncol. 2021;16:130.PubMedPubMedCentralCrossRef Khoo SC, Nabil S, Fauzi AA, Yunus SSM, Ngeow WC, Ramli R. Predictors of osteoradionecrosis following irradiated tooth extraction. Radiat Oncol. 2021;16:130.PubMedPubMedCentralCrossRef
49.
go back to reference Wang TH, Liu CJ, Chao TF, Chen TJ, Hu YW. Risk factors for and the role of dental extractions in osteoradionecrosis of the jaws: a national-based cohort study. Head Neck. 2017;39:1313–21.PubMedCrossRef Wang TH, Liu CJ, Chao TF, Chen TJ, Hu YW. Risk factors for and the role of dental extractions in osteoradionecrosis of the jaws: a national-based cohort study. Head Neck. 2017;39:1313–21.PubMedCrossRef
50.
go back to reference Jiang Y, Zhu X, Qu S. Incidence of osteoradionecrosis in patients who have undergone dental extraction prior to radiotherapy: a systematic review and meta-analysis. J Oral Maxillofac Surg Med Pathol. 2014;26:269–75.CrossRef Jiang Y, Zhu X, Qu S. Incidence of osteoradionecrosis in patients who have undergone dental extraction prior to radiotherapy: a systematic review and meta-analysis. J Oral Maxillofac Surg Med Pathol. 2014;26:269–75.CrossRef
51.
go back to reference Nabil S, Samman N. Incidence and prevention of osteoradionecrosis after dental extraction in irradiated patients: a systematic review. Int J Oral Maxillofac Surg. 2011;40:229–43.PubMedCrossRef Nabil S, Samman N. Incidence and prevention of osteoradionecrosis after dental extraction in irradiated patients: a systematic review. Int J Oral Maxillofac Surg. 2011;40:229–43.PubMedCrossRef
52.
go back to reference Beech NM, Porceddu S, Batstone MD. Radiotherapy-associated dental extractions and osteoradionecrosis. Head Neck. 2017;39:128–32.PubMedCrossRef Beech NM, Porceddu S, Batstone MD. Radiotherapy-associated dental extractions and osteoradionecrosis. Head Neck. 2017;39:128–32.PubMedCrossRef
53.
go back to reference Balermpas P, van Timmeren JE, Knierim DJ, Guckenberger M, Ciernik IF. Dental extraction, intensity-modulated radiotherapy of head and neck cancer, and osteoradionecrosis: a systematic review and meta-analysis. Strahlenther Onkol. 2022;198:219–28.PubMedPubMedCentralCrossRef Balermpas P, van Timmeren JE, Knierim DJ, Guckenberger M, Ciernik IF. Dental extraction, intensity-modulated radiotherapy of head and neck cancer, and osteoradionecrosis: a systematic review and meta-analysis. Strahlenther Onkol. 2022;198:219–28.PubMedPubMedCentralCrossRef
54.
go back to reference Xu J, Zheng Z, Fang D, Gao R, Liu Y, Fan ZP, et al. Early-stage pathogenic sequence of jaw osteoradionecrosis in vivo. J Dent Res. 2012;91:702–8.PubMedCrossRef Xu J, Zheng Z, Fang D, Gao R, Liu Y, Fan ZP, et al. Early-stage pathogenic sequence of jaw osteoradionecrosis in vivo. J Dent Res. 2012;91:702–8.PubMedCrossRef
55.
go back to reference Delanian S, Lefaix JL. The radiation-induced fibroatrophic process: therapeutic perspective via the antioxidant pathway. Radiother Oncol. 2004;73:119–31.PubMedCrossRef Delanian S, Lefaix JL. The radiation-induced fibroatrophic process: therapeutic perspective via the antioxidant pathway. Radiother Oncol. 2004;73:119–31.PubMedCrossRef
56.
go back to reference Lyons A, Ghazali N. Osteoradionecrosis of the jaws: current understanding of its pathophysiology and treatment. Br J Oral Maxillofac Surg. 2008;46:653–60.PubMedCrossRef Lyons A, Ghazali N. Osteoradionecrosis of the jaws: current understanding of its pathophysiology and treatment. Br J Oral Maxillofac Surg. 2008;46:653–60.PubMedCrossRef
57.
go back to reference Russo D, Mariani P, Caponio VCA, Lo Russo L, Fiorillo L, Zhurakivska K, et al. Development and validation of prognostic models for oral squamous cell carcinoma: a systematic Review and Appraisal of the literature. Cancers (Basel). 2021;13(22):5755.PubMedCrossRef Russo D, Mariani P, Caponio VCA, Lo Russo L, Fiorillo L, Zhurakivska K, et al. Development and validation of prognostic models for oral squamous cell carcinoma: a systematic Review and Appraisal of the literature. Cancers (Basel). 2021;13(22):5755.PubMedCrossRef
Metadata
Title
The predictive value of pretreatment hemoglobin-to-platelet ratio on osteoradionecrosis incidence rates of locally advanced nasopharyngeal cancer patients managed with concurrent chemoradiotherapy
Authors
Busra Yilmaz
Efsun Somay
Erkan Topkan
Ahmet Kucuk
Berrin Pehlivan
Ugur Selek
Publication date
01-12-2023
Publisher
BioMed Central
Published in
BMC Oral Health / Issue 1/2023
Electronic ISSN: 1472-6831
DOI
https://doi.org/10.1186/s12903-023-02937-9

Other articles of this Issue 1/2023

BMC Oral Health 1/2023 Go to the issue